A federal watchdog agency is making drug prices a primary focal point of investigations in the coming year.
A New York attorney who operated two drug treatment programs has been charged with bilking the state’s Medicaid program.
A trio of senators is now asking Mylan to return at least $50 million in overpayments for EpiPens made by the Department of Defense.
An appeals court tries to answer an important fraud question that's been plaguing hospice care for decades: When is someone terminally ill?
The University of Utah healthcare system has introduced a $10 life-saving EpiKit to compete with the skyrocketing cost of the EpiPen.
New research shows Medicare spends approximately half a billion dollars annually on genetic blood tests that offer little to no clinical benefit.
Since our last list of notorious CEOs, more industry executives have misbehaved--some accused of price gouging, others for committing fraud and embezzling…
Both payers and providers are considered a top target for medical identity fraud, but better identity verification and a layered approach to fraud detection…
Three former sales managers at Warner Chilcott were sentenced for using protected patient information as part of a scheme to increase sales.
A new report from the OIG once again outlines basic recommendations to stop improper payments for personal care services, so why won't CMS listen?